NCT03981094View on ClinicalTrials.gov

A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

July 27, 2019

Study Completion Date

July 30, 2019

Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Interventions
DRUG

BMS-986278

suspension

DRUG

Pirfenidone

capsule

Trial Locations (1)

84124

PRA Health Sciences - Salt Lake, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY